4//SEC Filing
Cranston Lynda Sarah 4
Accession 0001213900-18-008712
CIK 0001498382other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:40 PM ET
Size
10.9 KB
Accession
0001213900-18-008712
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2018-06-29$3.20/sh+71$227→ 2,699 total(indirect: Held by J.G. Cranston & Associates, Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:40 PM ET
- Size
- 10.9 KB